S. Boselli

576 total citations
20 papers, 367 citations indexed

About

S. Boselli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, S. Boselli has authored 20 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in S. Boselli's work include Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). S. Boselli is often cited by papers focused on Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). S. Boselli collaborates with scholars based in Italy, France and United States. S. Boselli's co-authors include Filippo de Braud, Tommaso De Pas, Gianluca Spitaleri, Francesca Toffalorio, Cristina Noberasco, Edoardo Botteri, Angelo Delmonte, Nicole Rotmensz, Aron Goldhirsch and Paolo Veronesi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

S. Boselli

20 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Boselli Italy	9	147	128	108	100	98	20	367
Kuniyoshi Tamaki Japan	10	168 1.1×	255 2.0×	54 0.5×	44 0.4×	216 2.2×	26	434
Clarence Eng United States	8	55 0.4×	130 1.0×	79 0.7×	21 0.2×	158 1.6×	16	342
H. Franklin Netherlands	9	46 0.3×	416 3.3×	215 2.0×	73 0.7×	55 0.6×	11	535
Trupti Pai India	11	43 0.3×	109 0.9×	85 0.8×	19 0.2×	65 0.7×	48	268
Maria Alessandra Calegari Italy	10	65 0.4×	220 1.7×	109 1.0×	10 0.1×	70 0.7×	43	361
Yawara Funasako Japan	11	66 0.4×	171 1.3×	106 1.0×	24 0.2×	158 1.6×	18	399
Tomoyuki Aruga Japan	13	91 0.6×	230 1.8×	132 1.2×	32 0.3×	161 1.6×	59	403
Shawn Steen United States	11	60 0.4×	148 1.2×	45 0.4×	11 0.1×	99 1.0×	22	334
Jiaqin Yan China	13	338 2.3×	310 2.4×	36 0.3×	30 0.3×	38 0.4×	39	534

Countries citing papers authored by S. Boselli

Since Specialization

Citations

This map shows the geographic impact of S. Boselli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Boselli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Boselli more than expected).

Fields of papers citing papers by S. Boselli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Boselli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Boselli. The network helps show where S. Boselli may publish in the future.

Co-authorship network of co-authors of S. Boselli

This figure shows the co-authorship network connecting the top 25 collaborators of S. Boselli. A scholar is included among the top collaborators of S. Boselli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Boselli. S. Boselli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spada, Francesca, Samuele Frassoni, S. Boselli, et al.. (2024). Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers. ESMO Open. 9(11). 103959–103959. 1 indexed citations

Spada, Francesca, Nicola Fazio, Guido Bonomo, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 6. 280–280. 4 indexed citations

Catania, Chiara, Edoardo Botteri, Massimo Barberis, et al.. (2015). Molecular Features and Clinical Outcome of Lung Malignancies in Very Young People. Future Oncology. 11(8). 1211–1221. 11 indexed citations

Catania, Chiara, Irène Feroce, Monica Barile, et al.. (2015). Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires—an Italian exploratory study. Journal of Cancer Research and Clinical Oncology. 142(3). 633–648. 6 indexed citations

Spitaleri, Gianluca, Antonio Toesca, Edoardo Botteri, et al.. (2013). Breast phyllodes tumor: A review of literature and a single center retrospective series analysis. Critical Reviews in Oncology/Hematology. 88(2). 427–436. 141 indexed citations

Pas, Tommaso De, Gerardo Rosati, Gianluca Spitaleri, et al.. (2011). Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination. Chemotherapy. 57(3). 217–224. 3 indexed citations

Joensuu, Heikki, Filippo de Braud, Tommaso De Pas, et al.. (2011). Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study. British Journal of Cancer. 104(11). 1686–1690. 54 indexed citations

Gregorc, Vanesa, Filippo de Braud, Tommaso Martino De Pas, et al.. (2011). Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors. Clinical Cancer Research. 17(7). 1964–1972. 44 indexed citations

Braud, Filippo de, Chiara Catania, Cristina Masini, et al.. (2010). Combinations of the immunocytokine F16-IL2 with doxorubicin or with paclitaxel investigated in phase Ib studies in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). e13017–e13017. 11 indexed citations

10.

Meglio, Giovanni Di, Cristian Massacesi, Davide Radice, et al.. (2010). Carboplatin with etoposide in patients with extrapulmonary “aggressive” neuroendocrine carcinoma.. Journal of Clinical Oncology. 28(15_suppl). e13072–e13072. 5 indexed citations

11.

Noberasco, Cristina, Gianluca Spitaleri, Patrizia Mancuso, et al.. (2009). Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents. Oncology. 77(6). 358–365. 6 indexed citations

12.

Citterio, Giovanni, Filippo de Braud, Vanesa Gregorc, et al.. (2009). Phase Ib study of NGR-hTNF, a selective vascular targeting agent (VTA), in combination with cisplatin in patients with refractory solid tumors. Journal of Clinical Oncology. 27(15_suppl). 3570–3570. 1 indexed citations

13.

Toffalorio, Francesca, Elisa Giovannetti, Tommaso De Pas, et al.. (2009). Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer. The Pharmacogenomics Journal. 10(3). 180–190. 15 indexed citations

14.

Lorizzo, K., Nicola Fazio, Davide Radice, et al.. (2008). Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 64(2). 301–306. 11 indexed citations

15.

Braud, Filippo de, Vanesa Gregorc, Tommaso Martino De Pas, et al.. (2008). A phase I study to define the optimal low dose of NGR-hTNF, a novel vascular targeting agent (VTA), in combination with cisplatin in patients (pts) with solid tumors. Journal of Clinical Oncology. 26(15_suppl). 14647–14647. 2 indexed citations

16.

Zampino, Maria Giulia, Elena Magni, Cristian Massacesi, et al.. (2007). First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first‐line treatment for metastatic colorectal cancer. Cancer. 110(4). 752–758. 26 indexed citations

17.

Zampino, Maria Giulia, Elena Magni, Laura Zorzino, et al.. (2007). Epidermal growth factor receptor (EGFR) serum level may predict response in patients with advanced colorectal cancer (ACC) treated with gefitinib. Journal of Clinical Oncology. 25(18_suppl). 4119–4119. 1 indexed citations

18.

Fazio, Nicola, Giuseppe Petralia, Patrizia Mancuso, et al.. (2007). Thalidomide in patients with advanced hepatocellular carcinoma: A clinical/biological study. Journal of Clinical Oncology. 25(18_suppl). 15076–15076. 1 indexed citations

19.

Pas, Tommaso De, Carlo Putzu, Giuseppe Curigliano, et al.. (2006). A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients. Lung Cancer. 54(3). 359–364. 5 indexed citations

20.

Zampino, Maria Giulia, K. Lorizzo, Cristian Massacesi, et al.. (2005). First-line gefitinib combined with simplified FOLFOX-6 in patients with epidermal growth factor receptor-positive advanced colorectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3659–3659. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact